Cas no 582-60-5 (5,6-Dimethylbenzimidazole)
5,6-Dimethylbenzimidazole Chemical and Physical Properties
Names and Identifiers
-
- 5,6-Dimethyl-1H-benzo[d]imidazole
- 5,6-Dimethylbenzimidazole
- 5,6-Dimethyl-1H-benzimidazole
- Dimethylbenzimidazole
- Dimedazol
- Dimedazole
- Dimesol
- Dimezol
- 1H-Benzimidazole, 5,6-dimethyl-
- Benzimidazole, 5,6-dimethyl-
- 5.6-Dimethylbenzimidazole
- 5,6-dimethyl-1H-benzoimidazole
- LJUQGASMPRMWIW-UHFFFAOYSA-N
- 553XI1DS20
- 5,6-dimethyl-1H-1,3-benzodiazole
- 5,6-Dimethyl Benz
- Dimezol base
- CHEBI:15890
- 5,6-Dimethyl Benzimidazole
- AS-10901
- AM20040774
- Dimezol (VAN)
- DB02591
- AB00375938-02
- CS-W018227
- s3097
- NSC68316
- HY-W017511
- NSC-68316
- NS00015324
- BDBM50208872
- Q-100667
- UNII-553XI1DS20
- SCHEMBL3893948
- DTXSID70870631
- BRN 0116595
- 5,6-DIMETHYLBENZIMIDAZOLE [MI]
- bmse000881
- FT-0619833
- HMS1659L03
- C03114
- 5,6-Dimethylbenzimidazole, >=99%
- Q15269676
- InChI=1/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11
- 5,6-Dimethylbenzimidazole, purum, >=99.0% (NT)
- DimezolDimedazol
- 5-23-06-00454 (Beilstein Handbook Reference)
- SCHEMBL312977
- B97E9041-BA87-4952-8BE7-E80B4E480262
- 5,6-dimethylbenzoimidazole
- 1H-Benzimidazole,6-dimethyl-
- NSC 68316
- AC-8359
- AI3-52806
- BB 0241929
- CHEMBL351132
- MFCD00005603
- F17509
- EN300-16463
- D1345
- 582-60-5
- F3145-1021
- A831807
- EINECS 209-488-1
- Z55928828
- AKOS000121551
- Benzimidazole,6-dimethyl-
- ALBB-021295
- STK001228
-
- MDL: MFCD00005603
- Inchi: 1S/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11)
- InChI Key: LJUQGASMPRMWIW-UHFFFAOYSA-N
- SMILES: N1C=NC2C=C(C)C(C)=CC1=2
- BRN: 0116595
Computed Properties
- Exact Mass: 146.08400
- Monoisotopic Mass: 146.084398
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 2.4
- Topological Polar Surface Area: 28.7
Experimental Properties
- Color/Form: No data available
- Density: 1.0976 (rough estimate)
- Melting Point: 203.0 to 206.0 deg-C
- Boiling Point: 376.8°C at 760 mmHg
- Flash Point: 208.6±5.7 °C
- Refractive Index: 1.5600 (estimate)
- Solubility: Soluble in ethanol (50 mg/ml).
- Water Partition Coefficient: dissolution
- PSA: 28.68000
- LogP: 2.17970
- Merck: 3236
- Solubility: Soluble in water.
5,6-Dimethylbenzimidazole Security Information
- Signal Word:Warning
- Hazard Statement: H315-H319-H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Safety Instruction: S24/25
- RTECS:DD8280000
- TSCA:Yes
- Storage Condition:Sealed in dry,Room Temperature
- Safety Term:S24/25
5,6-Dimethylbenzimidazole Customs Data
- HS CODE:29339990
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5,6-Dimethylbenzimidazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | D1345-25g |
5,6-Dimethylbenzimidazole |
582-60-5 | 99.0%(GC&T) | 25g |
¥355.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | D835A-100g |
5,6-Dimethylbenzimidazole |
582-60-5 | 99% | 100g |
¥282.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | D835A-25g |
5,6-Dimethylbenzimidazole |
582-60-5 | 99% | 25g |
¥88.0 | 2022-05-30 | |
| Chemenu | CM157929-500g |
5,6-Dimethyl-1H-benzimidazole |
582-60-5 | 98% | 500g |
$204 | 2021-06-08 | |
| Chemenu | CM157929-1000g |
5,6-Dimethyl-1H-benzimidazole |
582-60-5 | 98% | 1000g |
$337 | 2021-06-08 | |
| Fluorochem | 222607-1g |
5,6-Dimethyl-1H-benzo[d]imidazole |
582-60-5 | 95% | 1g |
£10.00 | 2022-02-28 | |
| S e l l e c k ZHONG GUO | S3097-100mg |
5,6-Dimethylbenzimidazole |
582-60-5 | 99.45% | 100mg |
¥794.43 | 2023-09-16 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T4824-100 mg |
5,6-Dimethylbenzimidazole |
582-60-5 | 99.94% | 100MG |
¥485.00 | 2022-03-01 | |
| Apollo Scientific | OR6715-25g |
5,6-Dimethyl-1H-benzimidazole |
582-60-5 | 99% | 25g |
£17.00 | 2025-03-21 | |
| Apollo Scientific | OR6715-100g |
5,6-Dimethyl-1H-benzimidazole |
582-60-5 | 99% | 100g |
£39.00 | 2025-02-20 |
5,6-Dimethylbenzimidazole Suppliers
5,6-Dimethylbenzimidazole Related Literature
-
Siddappa Patil,Anthony Deally,Brendan Gleeson,Helge Müller-Bunz,Francesca Paradisi,Matthias Tacke Metallomics 2011 3 74
-
Ekaterina A. Martynova,Thomas Scattolin,Enrico Cavarzerani,Min Peng,Kristof Van Hecke,Flavio Rizzolio,Steven P. Nolan Dalton Trans. 2022 51 3462
-
Xiao Xiao Wang,Baoyi Yu,Kristof Van Hecke,Guang Hua Cui RSC Adv. 2014 4 61281
-
Mingqin Huang,Shengzu Duan,Xueqiong Ma,Bicheng Cai,Dongmei Wu,Yan Li,Liang Li,Hongbin Zhang,Xiaodong Yang Med. Chem. Commun. 2019 10 1027
-
Mingqin Huang,Shengzu Duan,Xueqiong Ma,Bicheng Cai,Dongmei Wu,Yan Li,Liang Li,Hongbin Zhang,Xiaodong Yang Med. Chem. Commun. 2019 10 1027
Additional information on 5,6-Dimethylbenzimidazole
5,6-Dimethylbenzimidazole (CAS No. 582-60-5): An Overview of Its Properties, Applications, and Recent Research
5,6-Dimethylbenzimidazole (CAS No. 582-60-5) is a versatile organic compound that has garnered significant attention in the fields of chemistry, biology, and pharmaceutical research. This compound is characterized by its unique molecular structure, which consists of a benzimidazole ring with two methyl groups attached at the 5 and 6 positions. The chemical formula of 5,6-Dimethylbenzimidazole is C9H10N2, and it has a molecular weight of 146.19 g/mol.
The physical properties of 5,6-Dimethylbenzimidazole are notable for its white crystalline appearance and its solubility in common organic solvents such as ethanol and dimethyl sulfoxide (DMSO). These properties make it an ideal candidate for various applications in chemical synthesis and biological studies. Additionally, the compound exhibits good thermal stability, which is crucial for maintaining its integrity during experimental procedures.
In the realm of chemical synthesis, 5,6-Dimethylbenzimidazole serves as a valuable building block for the preparation of more complex molecules. Its reactivity and functional group versatility allow chemists to introduce it into a wide range of organic reactions, including coupling reactions, cyclizations, and nucleophilic substitutions. This makes it an essential reagent in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals.
One of the most significant applications of 5,6-Dimethylbenzimidazole is in the field of medicinal chemistry. Recent research has highlighted its potential as a lead compound for the development of novel therapeutic agents. For instance, studies have shown that derivatives of 5,6-Dimethylbenzimidazole exhibit potent antitumor activity against various cancer cell lines. These derivatives are believed to target specific cellular pathways involved in cancer progression, such as apoptosis induction and cell cycle arrest.
Beyond its antitumor properties, 5,6-Dimethylbenzimidazole has also been investigated for its potential in treating neurodegenerative diseases. Research conducted by a team at the University of California demonstrated that certain derivatives of this compound can effectively protect neurons from oxidative stress and prevent the aggregation of toxic proteins associated with conditions like Alzheimer's disease. These findings suggest that 5,6-Dimethylbenzimidazole could be a promising candidate for developing neuroprotective drugs.
In addition to its therapeutic applications, 5,6-Dimethylbenzimidazole has been explored for its use in diagnostic imaging. Scientists at the Massachusetts Institute of Technology have developed fluorescent probes based on this compound that can be used to visualize specific cellular structures with high sensitivity and selectivity. These probes have shown promise in improving the accuracy of medical imaging techniques such as fluorescence microscopy and positron emission tomography (PET).
The environmental impact of 5,6-Dimethylbenzimidazole is another area of active research. Studies have shown that this compound can be biodegraded by certain microorganisms under aerobic conditions. This biodegradability is an important consideration for ensuring the sustainability and environmental safety of products containing 5,6-Dimethylbenzimidazole.
In conclusion, 5,6-Dimethylbenzimidazole (CAS No. 582-60-5) is a multifaceted compound with a wide range of applications in chemical synthesis, medicinal chemistry, and diagnostic imaging. Its unique molecular structure and favorable physical properties make it an invaluable tool for researchers across various scientific disciplines. As ongoing research continues to uncover new possibilities for this compound, it is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.
582-60-5 (5,6-Dimethylbenzimidazole) Related Products
- 614-97-1(5-methyl-1H-1,3-benzodiazole)
- 106429-29-2(5-(Hydroxymethyl)-1H-benzimidazole)
- 216970-36-4(1H-Benzimidazole,6-ethynyl-)
- 267642-46-6(1H-1,3-benzodiazole-5,6-dicarbonitrile)
- 1792-41-2(2,5-Dimethyl-1H-benzimidazole)
- 109366-88-3(1H-Benzimidazole,5-ethyl-6-propyl-)
- 29096-75-1(2-Amino-5,6-dimethylbenzimidazole)
- 38837-60-4(1H-Naphth[2,3-d]imidazole,6,7-dimethyl-)
- 164648-60-6(1H-1,3-benzodiazol-6-ylmethanamine)
- 106148-67-8(1H-Benzimidazole,4,5,6,7-tetramethyl-)